Phases of Acute Hepatitis
Acute hepatitis typically progresses through four distinct clinical phases: the incubation phase, prodromal (pre-icteric) phase, icteric phase, and convalescent (recovery) phase, with a cholestatic variant representing an atypical prolonged course rather than a separate sequential phase.
Standard Clinical Phases
1. Incubation Phase
- Asymptomatic period following viral exposure
- Duration varies by hepatitis virus type (15-45 days for HAV, 45-180 days for HBV)
- Viral replication occurs without clinical manifestations
2. Prodromal (Pre-icteric) Phase
- Nonspecific symptoms develop before jaundice appears
- Typical duration: 3-10 days
- Manifestations include:
- Fatigue and malaise
- Anorexia and nausea
- Right upper quadrant discomfort
- Low-grade fever
- Arthralgias (particularly in hepatitis B) 1
- Transaminase elevation begins
3. Icteric Phase
- Jaundice develops as bilirubin rises
- Duration: 2-6 weeks in uncomplicated cases
- Clinical features:
- Dark urine precedes visible jaundice
- Scleral icterus and skin discoloration
- Prodromal symptoms often improve paradoxically
- Peak transaminase levels (typically >1000 U/L)
- Hepatomegaly on examination
4. Convalescent (Recovery) Phase
- Gradual resolution of symptoms and laboratory abnormalities
- Duration: weeks to months
- Progressive normalization of liver enzymes and bilirubin
- Complete recovery expected in typical cases
Cholestatic Variant: An Atypical Prolonged Course
The cholestatic phase is not a standard sequential phase but rather an uncommon variant pattern occurring in 5-10% of acute hepatitis A cases 2. This represents a distinct clinical entity with important management implications:
Key Characteristics of Cholestatic Hepatitis
- Prolonged duration: 80-130+ days (versus 4-8 weeks for typical acute hepatitis) 2
- Marked hyperbilirubinemia (often >10 mg/dL, can exceed 50 mg/dL) 3, 1
- Disproportionately elevated alkaline phosphatase and GGT relative to transaminases
- Prominent clinical features:
Diagnostic Considerations
The primary clinical challenge is distinguishing cholestatic viral hepatitis from:
- Drug-induced cholestatic liver injury (defined by alkaline phosphatase >2× ULN or ALT/AP ratio <2) 5
- Extrahepatic biliary obstruction
- Other causes of intrahepatic cholestasis 2
Ultrasound and ERCP are essential technological methods to exclude mechanical obstruction 2. The diagnosis requires maintaining high clinical suspicion while excluding alternative etiologies.
Management and Prognosis
- Prognosis remains excellent despite prolonged course 2
- Spontaneous resolution is the rule
- Corticosteroids may provide symptomatic relief (reducing pruritus, weakness, and jaundice) but do not alter disease duration and may predispose to relapse 3, 2, 1
- Ursodeoxycholic acid has been used with variable success 3
- Treatment is primarily supportive; specific therapy is justified only in markedly symptomatic patients 2
Relapsing Hepatitis: Another Atypical Pattern
A biphasic or relapsing form occurs in 6-10% of hepatitis A cases 1:
- Initial episode: 3-5 weeks
- Remission period with normal liver tests: 4-5 weeks
- Relapse mimicking initial acute hepatitis
- Total illness duration: 16-40 weeks
- IgM anti-HAV persists throughout the entire clinical course 1
Critical Clinical Pitfalls
Avoid misdiagnosing cholestatic viral hepatitis as biliary obstruction, which could lead to unnecessary invasive procedures. The combination of appropriate viral serology, imaging to exclude obstruction, and recognition of the characteristic prolonged but self-limited course is essential 2.
In endemic areas, distinguishing acute hepatitis B from chronic hepatitis B with acute exacerbation presents another diagnostic challenge, though this relates more to disease classification than phase identification 6.